Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

Best practice principles for cholesterol lowering

May 2007 Volume 14, Supplement 1 Br J Cardiol 2007;14(Suppl 1):S2-S15

Authors:
Nigel Capps, Marc Evans, Terry Mccormack, Jan Procter-King, Gershan Davis, Stewart Findlay, Clive Weston, Jonathan Morrell

Sponsorship statement: This is a sponsored supplement to The British Journal of Cardiology. Details of sponsorship can be found by downloading the PDF.

In 2006, 78% of patients with coronary heart disease (CHD) achieved the National Quality and Outcomes Framework (QOF) of the General Medical Services (GMS) target of 5.0 mmol/L for total cholesterol. This is a significant achievement in secondary prevention and shows that the standard of care in the UK is becoming aligned with that of the rest of Europe. Nevertheless, the UK still has one of the highest CHD mortality rates in Europe,2 and we need therefore to continue to work towards improving the quality of care and achieving more clinically meaningful targets for high-risk patients. The current targets outlined by the GMS for lipid lowering are less stringent than the newer evidence-based recommended targets of <4.0 mmol/L for total cholesterol and <2.0 mmol/L for low-density lipoprotein cholesterol (LDL-C) suggested by the recent Joint British Societies’ Guidelines on Prevention of Cardiovascular Disease in Clinical Practice (JBS2). supplement outlines a new treatment algorithm for suggested best practice for cholesterol lowering, incorporating the latest strategies and thinking.

In the near future, you will need to be a registered user to view full articles

Already a member? Login now

Disclaimer: UK prescribing information current at the date of publication of this supplement can be found by downloading the PDF. Medinews Cardiology Limited advises healthcare professionals to consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews Cardiology Limited cannot accept responsibility for any errors in prescribing which may occur.